Benzinga··NaGalera and Obsidian Merge in All-Stock Deal, $350M Financing Fuels TIL Therapy Push
Galera and Obsidian merge in all-stock deal with $350M financing, creating Obsidian Therapeutics ($OBX) focused on TIL cell therapies with funding through 2028.
GRTXclinical trialsmerger agreement